GlassScriptPhysician profile
Myra J Oswald
NPI 1942205232
$2,964.80
in general payments reported to CMS, 2019-2025
25 companies · $23.96 in 2025
The $23.96 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,390 · 2022: $551 · 2025: $23.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $23.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $23.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $565.58 | 2021-2022 | |
| Insulet Corporation | $435.49 | 2021-2022 | |
| Abbott Laboratories | $331.17 | 2021-2025 | Cardiomems |
| Esperion Therapeutics, INC. | $235.63 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $191.90 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $176.73 | 2021-2022 | |
| Lilly USA, LLC | $158.15 | 2021-2022 | |
| Novo Nordisk INC | $134.25 | 2021-2022 | |
| Abbvie INC. | $126.15 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $104.50 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $81.22 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $77.40 | 2021 | |
| Amarin Pharma, INC. | $46.00 | 2021 | |
| Ibsa Pharma INC. | $42.59 | 2021 | |
| Dexcom, INC. | $41.42 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $38.63 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $38.62 | 2021 | |
| Astellas Pharma US INC | $38.59 | 2021 | |
| Eisai INC. | $21.61 | 2021 | |
| Amryt Pharma Holdings LTD | $15.42 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.27 | 2022 | |
| Glaxosmithkline, LLC. | $13.54 | 2021 | |
| Amneal Pharmaceuticals LLC | $12.59 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.71 | 2021 | |
| Amgen INC. | $11.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Myra Oswald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.